Views & Analysis Evolving immunotherapy strategies in NSCLC Status of immunotherapies in non-small cell lung cancer (NSCLC).
Views & Analysis Is the NHS ready to use real-world evidence to treat cancer? Is NHS ready to use real-world data to find new therapies and ways to bring drugs to patients?
News Celgene hopes device + drug can tackle aggressive brain tumo... Novocure's Optune will be tested alongside investigational Celgene drug marizomib.
Views & Analysis UK funding of cancer drugs: right, wrong, or just plain conf... How do the countries of the UK fund cancer drugs today, and do they have the right approaches?
Views & Analysis Bowel cancer: improving rates of diagnosis Impact of bowel cancer home test on diagnosis.
Views & Analysis Five tech companies advancing against cancer New cancer tech devices for oncology screening, diagnosis and mental wellbeing.
News uniQure falls on long-term Huntington's gene therapy data uniQure's latest data drop for its gene therapy for Huntington's disease, under review in the US and UK, has spooked investors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
